203450-08-2

Basic information

• Product Name: 2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine
• Synonyms: 2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine
• CAS NO: 203450-08-2
• Molecular Formula: C21H14FN3
• Molecular Weight: 327.3543632
• Product Categories: 1,3,5-triazine
• Mol File: 203450-08-2.mol
• Article Data: 24

Chemical Properties

• Melting Point: 231.0 to 235.0 °C
• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine(203450-08-2)
• EPA Substance Registry System: 2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine(203450-08-2)

Safety Data

• Hazardous Substances Data: 203450-08-2(Hazardous Substances Data)

Usage

Description

2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine, also known as FDPT, is an organic compound belonging to the triazine class. It is a crystalline solid with unique physical properties such as strong fluorescence emission and good photostability, making it a versatile fluorescent probe for various applications in research and industry.

Uses

Used in Research and Industry:
2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine is used as a fluorescent probe for detecting metal ions and studying biological and chemical systems due to its strong fluorescence emission and good photostability.
Used in Sensor Development:
2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine is used as a component in the development of sensors for detecting metal ions, leveraging its fluorescent properties for sensitive and selective detection.
Used in Optoelectronic Devices:
2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine is used as a material in optoelectronic devices, taking advantage of its strong fluorescence and photostability for improved device performance.
Used in Medicinal Chemistry:
2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine is being studied for its potential antiproliferative and anticancer properties, making it a compound of interest for the development of new therapeutic agents.

Upstream product

• 1670-14-0 benzamidine monohydrochloride 
• 352-11-4 1-chloromethyl-4-fluorobenzene 
• 116856-96-3 2,5-Bis-(4-nitro-phenyl)-4,6-diphenyl-2,5-dihydro-[1,2,3,5]tetrazine 
• 116856-91-8 1,2-bis(p-nitrophenylazo)stilbene 
• 2339-59-5 4-fluorobenzamidine 
• 134-81-6 benzil 
• 459-56-3 4-fluorobenzylic alcohol 
• 618-39-3 benzamidin 
• 459-57-4 4-fluorobenzaldehyde 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 3842-55-5 2-chloro-4,6-diphenyl-1,3,5-triazine 
• 1765-93-1 4-fluoroboronic acid 
• 140-75-0 para-fluorobenzylamine 
• 352-32-9 p-fluorotoluene 

Downstream Products

• 1345622-25-4 C₄₁H₂₇N₅ 

Relevant articles and documents

The role of fluorine-substitution on the π-bridge in constructing effective thermally activated delayed fluorescence molecules

Two thermally activated delayed fluorescence (TADF) emitters 9′-(4-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl)-9′H-9,3′:6′,9′′-tercarbazole (TCTZ-F) and 9′-(4-(4,6-diphenyl-1,3,5-triazin-2-yl)-2,6-difluorophenyl)-9′H-9,3′:6′,9′′-tercarbazole (TCTZ-2

COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

The present invention provides a compound represented by chemical formula and an organic light emitting device including the same.

METHOD FOR PRODUCING TRIAZINE COMPOUND

To provide a method for easily and efficiently producing a triazine compound from a nitrile compound and a trihalide compound under a mild production condition using a metal catalyst.SOLUTION: There is provided a method for producing a triazine compound by reacting a nitrile compound represented by the formula (1): R1-CN (wherein, R1 is an aryl group which may be substituted with one or more substituents or a heteroaryl group which may be substituted with one or more substituents) and a trihalide compound represented by the formula (2): R2-CX3 (wherein, R2 is an aryl group which may be substituted with one or more substituents or a heteroaryl group which may be substituted with one or more substituents and X is halogen) in the presence of a catalyst containing a Group 5 metal compound and an ammonium salt and optionally a metal halide compound.SELECTED DRAWING: None